This issue features the latest consensus paper of the European Bifurcation Club; data from SYNTAX trial five-year follow-up on the impact of chronic kidney disease; renal artery anatomy in hypertension assessed by quantitative analysis of renal angiography; new CTO terminology for the reverse CART technique; in-hospital outcomes after TAVI or SAVR in younger patients and long-term outcomes of high-risk and inoperable patients receiving first-generation TAVI devices; the efficacy of early versus delayed P2Y12 inhibition in PCI for STEMI is also examined and the new BioNIR stent is introduced.
Strategy trials in antithrombotic therapyRead the editorial on "Trials of antithrombotic therapy in percutaneous coronary intervention: what evidence do we need to optimise our practice?" by Thomas Cuisset and Davide Capodanno
EBC consensus paperConsult the article on "Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club" by Francesco Burzotta, et al.
view the full table of contents